Skip to content
OpenFederal grantOpen to for-profit businessesPAR-28-042

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

National Institutes of HealthCloses Nov 16, 2029(1094 days left)

Does this fit your business?

This is an NIH research grant for validating cancer biomarker assays, not a general business grant. It fits labs and companies doing cancer-related assay validation work on human samples. If your business is not doing biomedical R&D, do not bother applying.

Best for
Small businesses doing cancer biomarker or assay R&D, Biotech and healthcare research organizations, Universities and nonprofits with cancer research labs, U.S.-based research teams with a defined clinical need
Not for
Retail, construction, logistics, or software businesses with no biomedical research, Foreign organizations or non-U.S. components of U.S. organizations, Organizations seeking general operating or startup funding
Estimated fit by industry, best first
IndustryEstimated fit
Healthcare & BiotechMatches your industry (clinical)
78
Strong Match
Arts & CultureLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Education & TrainingLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech
54
Possible Match
Environment & ConservationLimit: Nothing in this notice points to environment & conservation
54
Possible Match
Housing & Real EstateLimit: Nothing in this notice points to housing & real estate
54
Possible Match
Show all 15 industries
Estimated fit by industry, best first
IndustryEstimated fit
Social Services & NonprofitLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Technology & SoftwareLimit: Nothing in this notice points to technology & software
54
Possible Match
Food & BeverageLimit: Nothing in this notice points to food & beverage
53
Possible Match
ManufacturingLimit: Nothing in this notice points to manufacturing
52
Possible Match
Agriculture & FarmingLimit: Nothing in this notice points to agriculture & farming
51
Possible Match
Finance & BankingLimit: Nothing in this notice points to finance & banking
50
Possible Match
Construction & InfrastructureLimit: Nothing in this notice points to construction & infrastructure
49
Possible Match
Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce
49
Possible Match
Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics
49
Possible Match

These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.

What this funds

Money can be used for
Research, R&D
Who can apply
Small businesses, For-profit companies, Nonprofits, State and local governments, Tribal governments and organizations, Colleges and universities, Other applicants (see eligibility)

Questions about this grant

When is the application deadline?
The application deadline is November 16, 2029.
Who can apply for this grant?
Eligible applicants include small businesses, for-profit organizations other than small businesses, nonprofits (with or without 501(c)(3) status), private and public institutions of higher education, state, county, city, tribal, and special district governments, public housing authorities, and independent school districts. Foreign organizations and non-domestic components of U.S. organizations are not eligible.
Can a sole proprietor or single-member LLC apply?
The facts do not specifically address sole proprietors or single-member LLCs. Small businesses are listed as eligible, but you should check Section III of the NOFO for details.
Can a nonprofit apply?
Yes. Nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status, other than institutions of higher education, are both listed as eligible.

Summary

NIH cooperative agreement (UH2/UH3 or UH3) funding analytical and clinical validation of biomarker assays for cancer detection, diagnosis, prognosis, treatment response, prevention, and toxicity. Eligible applicants include small businesses, for-profits, nonprofits, universities, state/local/tribal governments, and other organizations; foreign entities are ineligible.

About this grant

The purpose of the Notice of Funding Opportunity (NOFO) is to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, monitoring, prediction of response or resistance to treatment, cancer prevention and control, as well as pharmacodynamic markers and markers of toxicity. Utilizing either a phased UH2/UH3 or a standalone UH3 mechanism, funding will facilitate laboratory optimization and clinical validation of assays that work on human samples and address a clearly defined cancer-related clinical need within a well-specified intended use.

Who can apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Topics and uses of funds

Topics

  • Health
  • Science
  • Cancer research

Program contact

National Institutes of HealthNCICDPNOFO@mail.nih.gov301-402-2541

Open opportunities funding similar work, from the same funder or in the same place.